Efficacy and Safety of Twice-Yearly Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): The Phase III Randomized, Double-Blind, Placebo-Controlled Replicate ANCHOR-1/2 Trials
第一作者机构:[1]Eastern Virginia Med Sch, Norfolk, VA USA
推荐引用方式(GB/T 7714):
Han Joseph,Cornet Marjolein,Mullol Joaquim,et al.Efficacy and Safety of Twice-Yearly Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): The Phase III Randomized, Double-Blind, Placebo-Controlled Replicate ANCHOR-1/2 Trials[J].JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY.2025,155(2):AB443-AB443.
APA:
Han, Joseph,Cornet, Marjolein,Mullol, Joaquim,De Corso, Eugenio,Turel, Nesil Keles...&Gevaert, Philippe.(2025).Efficacy and Safety of Twice-Yearly Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): The Phase III Randomized, Double-Blind, Placebo-Controlled Replicate ANCHOR-1/2 Trials.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,155,(2)
MLA:
Han, Joseph,et al."Efficacy and Safety of Twice-Yearly Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): The Phase III Randomized, Double-Blind, Placebo-Controlled Replicate ANCHOR-1/2 Trials".JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 155..2(2025):AB443-AB443